Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders
- 1 October 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 352 (9136) , 1285
- https://doi.org/10.1016/s0140-6736(05)70493-1
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some AnswersBlood, 1998
- IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's LymphomaBlood, 1997
- Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ TransplantationNew England Journal of Medicine, 1991